Suzanne Fleming

Suzanne Fleming

Nessuna posizione attualmente
65 anni
Health Technology
Commercial Services
Finance

Profilo

Suzanne Fleming is currently the Chief Accounting Officer at Beam Therapeutics, Inc. She previously held positions as the Senior Director-Finance at TransForm Pharmaceuticals, Inc. from 2003 to 2005, Principal at Transkaryotic Therapies, Inc., Principal at Oculon Corp from 1991 to 1995, Principal at CytoTherapuetics, Inc. from 1995 to 1998, Vice President-Finance at AVEO Pharmaceuticals, Inc. from 2005 to 2013, Treasurer, Chief Financial & Accounting Officer at Epizyme, Inc. from 2017 to 2019, and Vice President-Finance at Foundation Medicine, Inc. from 2014 to 2017.
She obtained her undergraduate degree from Stonehill College, Inc.

Precedenti posizioni note di Suzanne Fleming

SocietàPosizioneFine
EPIZYME, INC. Direttore Finanziario/CFO 31/01/2019
FOUNDATION MEDICINE INC Corporate Officer/Principal 01/09/2017
AVEO PHARMACEUTICALS, INC. Direttore Finanziario/CFO 05/04/2011
Direttore Finanziario/CFO 01/01/2005
Corporate Officer/Principal 01/01/1998
Vedi nel dettaglio l'esperienza di Suzanne Fleming

Formazione di Suzanne Fleming

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

66

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Commercial Services

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

  1. Mercati
  2. Insiders
  3. Suzanne Fleming
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA